Skip to content
- Halimi JM, et al. Effets vasculaires et rénaux des médicaments antiangiogéniques : recommandations françaises pour la pratique (SN, SFHTA, APNET, FFCD). Nephrol Ther 2008;4:602-15.
- Schmidinger M, et al. Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma. J Clin Oncol 2008;26:5204-12.
- Senkus E, et al. Cardiovascular effects of systemic cancer treatment. Cancer Treat Rev 2011;37(4):300-11.
- Suter TM, et al. Trastuzumab-associated cardiac adverse effects in the herceptin adjuvant trial. J Clin Oncol 2007;25:3859-65.